 Sequential immunopathologic study oral lichen planus tretinoin etretinate Twenty-five patients oral lichen planus histologic examination groups patients topical treatment tretinoin systemic treatment etretinate patients treatment control group immunopathologic study use monoclonal antibodies course treatment variation distribution phenotype inflammatory cells difference types treatment patients shorter evolution disease control patients